A national audit of the use of neuromuscular blocking drugs in cardiac anaesthesia

Briggs, S., Goodyear, P., Thomas, R., Strike, P. and Smith, D. (2006) A national audit of the use of neuromuscular blocking drugs in cardiac anaesthesia. Anaesthesia, 61, (1), p.95. (doi:10.1111/j.1365-2044.2005.04439.x).


Full text not available from this repository.


Residual neuromuscular blockade contributes to postoperative
morbidity and mortality and is more prevalent with long acting nondepolarising neuromuscular blocking drugs such as pancuronium [1]. Reducing time between surgery and extubation may lead to residual neuromuscular blockade in cardiac patients, particularly with long acting drugs [2]. We performed an audit of use of neuromuscular blocking drugs in the United Kingdom between 2002 and 2004.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1111/j.1365-2044.2005.04439.x
Additional Information: Abstracts presented at the spring meeting of the Association of Cardiothoracic Anaesthetists (ACTA) in Cambridge, July 2005
ISSNs: 0003-2409 (print)
Related URLs:
Keywords: time, pancuronium
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
R Medicine > RS Pharmacy and materia medica
Divisions : University Structure - Pre August 2011 > School of Medicine > Cancer Sciences
ePrint ID: 62694
Accepted Date and Publication Date:
Date Deposited: 02 Sep 2008
Last Modified: 31 Mar 2016 12:46
URI: http://eprints.soton.ac.uk/id/eprint/62694

Actions (login required)

View Item View Item